 |
|
|
| |
Phase 1 Results for ATI-2173, a Novel Active Site
Polymerase Inhibitor Nucleotide (ASPIN), in HBV-Infected Subjects
|
| |
| |
EASL International Liver Congress, June 23-26, 2021 JNJ-3989
D. Mayers,1 A. Jucov,2,3 I. Anastasiy,3 N. Ghicavii,2 L. Ogilvie,1 K. Squires,1 A. De La Rosa1
1Antios Therapeutics, Atlanta, GA, USA; 2ARENSIA Exploratory Medicine, Republican Clinical Hospital, Chisinau, Republic of Moldova; 3Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Republic of Moldova; 3ARENSIA Exploratory Medicine, Kiev, Ukraine
|
| |
|
|
|
|
|
